Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): A protocol for a randomised, double-blind, placebo-controlled, parallel-group trial

Fiona Gaughran*, Dominic Stringer, Michael Berk, Shubulade Smith, David Taylor, Eromona Whiskey, Sabine Landau, Robin Murray, Philip McGuire, Poonam Gardner-Sood, Gabriella Wojewodka, Simone Ciufolini, Harriet Jordan, Jessie Clarke, Lauren Allen, Amir Krivoy, Brendon Stubbs, Philippa Lowe, Maurice Arbuthnott, Shanaya RathodAndrew Boardman, Mudasir Firdosi, John J. McGrath

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): A protocol for a randomised, double-blind, placebo-controlled, parallel-group trial'. Together they form a unique fingerprint.

Medicine & Life Sciences